Fludeoxyglucose (18F)
- Generic Name
- Fludeoxyglucose (18F)
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11FO5
- CAS Number
- 63503-12-8
- Unique Ingredient Identifier
- 0Z5B2CJX4D
- Background
Fludeoxyglucose F 18 Injection is a positron emitting radiopharmaceutical containing no-carrier added radioactive 2-deoxy-2-[18F]fluoro-D-g1ucose, which is used for diagnostic purposes in conjunction with Positron Emission Tomography (PET). It is administered by intravenous injection.
- Indication
The uptake of 18F-FDG by tissues is a marker for the tissue uptake of glucose, which in turn is closely correlated with certain types of tissue metabolism.
...
- Associated Conditions
- Cancer, Coronary Artery Disease (CAD), Epileptic seizure, Left Ventricular Dysfunction
- Associated Therapies
- -
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in ...
Intrapatient intermetastatic heterogeneity (IIH) in metastatic castration-resistant prostate cancer (mCRPC) patients was studied using a triple-tracer PET imaging strategy. IIH was observed in 82.7% of patients, with 45.9% having at least one 18F-FDG-positive/68Ga-PSMA-negative lesion. Patients with IIH had shorter median overall survival. The study identified 12 different lesion imaging phenotypes, highlighting the need for further molecular characterization and personalized treatment strategies.
Related Clinical Trials:
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath